FAFahimeh Lavi Arab

Fahimeh Lavi Arab

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fahimeh Lavi Arab has a total of 97 co-authors. Here are the top co-authors by number of shared publications:

  • Nafiseh Sadat Tabasi

    Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    6 shared publications
  • Mahmoud Mahmoudi

    Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    5 shared publications
  • Mahmoud Mahmoudi

    Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    5 shared publications
  • Melika Hadad Tehran

    Immunology Research Center Mashhad University of Medical Sciences Mashhad Iran

    5 shared publications
  • Farid Zeynali

    Department of Urology, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran

    4 shared publications
  • Fatemeh Faraji

    Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran

    4 shared publications

Latest Publications

  • Comparative Effects of Lacticaseibacillus rhamnosus and Lactobacillus delbrueckii on the Proliferative, Anti-apoptotic, and Tolerogenic Properties of Adipose-Derived Mesenchymal Stem Cells

    by Sahar Khorasani, Fatemeh Faraji, Atefeh Alaei, Mohammadali Nahayati, Nafiseh Sadat Tabasi, Nazanin Forghani, Fahimeh Lavi Arab, Mahmoud Mahmoudi

  • Targeting Abdominal Aortic Aneurysms with Multipotent Mesenchymal Stromal/Stem Cells: Insights into Immunological Effects

    by Seyed Mohammad Sajjadi, Fahimeh Lavi Arab

    An abdominal aortic aneurysm (AAA) is a serious vascular disease characterized by progressive dilation of the abdominal aorta, resulting in an increased risk of rupture. AAA develops through multiple pathogenic mechanisms, including chronic inflammation, extracellular matrix (ECM) degradation, oxidative stress, and vascular smooth muscle cell (VSMC) apoptosis. Surgical intervention is the primary treatment for AAA; however, no effective pharmacological therapies are currently available to halt or reverse disease progression. This review evaluates the therapeutic potential of multipotent mesenchymal stromal/stem cells (MSCs) for AAA, with particular emphasis on their immunomodulatory and regenerative properties. Preclinical studies suggest that MSCs can attenuate AAA progression in animal models by modulating the inflammatory microenvironment, reducing matrix metalloproteinase activity, and promoting tissue repair. In addition, interactions between MSCs and various immune cells decrease inflammatory responses, thereby positively impacting the structure of the aortic wall. Collectively, the available evidence highlights the broad therapeutic potential of MSCs in modulating key molecular and cellular pathways involved in AAA progression. Given their ability to modulate the immune system and promote vascular regeneration, MSCs may have significant potential for developing disease-modifying therapies for AAA. By targeting key pathogenic processes involved in AAA progression, MSCs offer the potential to complement existing surgical management and address mechanisms that are not targeted by current therapies. However, additional well-designed laboratory-based and clinical studies are needed to optimize MSC-based therapeutic strategies and to establish their long-term efficacy and safety before clinical translation.

  • Open Access

    The Therapeutic Effects of Crocus sativus L . and Its Constituents on the Improving Treatment of Azoospermia: A Narrative Review

    by Faraz Khakshour, Melika Hadad Tehran, Jamal Jalili Shahri, Farid Zeynali, Fahimeh Lavi Arab

    Background and Aims: Azoospermia, defined as the complete absence of sperm in the ejaculate, is a major cause of male infertility and is classified into obstructive and non‐obstructive forms. While obstructive azoospermia is primarily mechanical in origin, non‐obstructive azoospermia (NOA) is characterized by impaired spermatogenesis and is frequently associated with oxidative stress, inflammation, and hormonal dysregulation. Crocus sativus L . and its bioactive constituents exhibit antioxidant and anti‐inflammatory properties that may target underlying pathophysiological mechanisms involved in NOA. This review discusses the potential adjunctive role of Crocus sativus L . in the context of NOA, with emphasis on oxidative stress–related pathways. Methods: This paper is a narrative review identified through relevant literature of electronic databases, including PubMed, Scopus, Web of Science, and Google Scholar. Peer‐reviewed experimental studies written in English that examined the antioxidant and anti‐inflammatory effects of Crocus sativus L . and its bioactive compounds on male reproductive health. Results: Available studies suggest that Crocus sativus L . bioactives may help attenuate oxidative stress, modulate inflammatory mediators, and support testicular structure and spermatogenesis in experimental models of chemical, radiation, and metabolic injury. Evidence indicates improvements in antioxidant enzyme activity, reductions in lipid peroxidation, and potential preservation of hormonal balance. However, clinical data are limited, and variability in dosage, extract composition, and study design precludes definitive conclusions about reproductive outcomes. Conclusion: Crocus sativus L . and its bioactive compounds could have supportive effects in contexts of testicular oxidative and inflammatory stress, but their clinical relevance in NOA remains uncertain. Further well‐controlled human studies are needed to clarify their potential therapeutic role.

  • Innovative treatment approaches for azoospermia: causes, emerging techniques, and future directions.

    by Faraz Khakshour, Melika Hadad Tehran, Fahimeh Lavi Arab

    Azoospermia, particularly non-obstructive azoospermia (NOA), is a major cause of male infertility and remains difficult to treat due to its complex hormonal, genetic, and immunological etiologies. The purpose of this review is to examine the biological, hormonal, genetic, and immunological mechanisms underlying azoospermia, with a specific focus on recent advances in regenerative and genetic therapies aimed at restoring spermatogenesis and fertility.This narrative review summarizes and analyzes published experimental, preclinical, and clinical studies focusing on the biological, hormonal, genetic, and immunological aspects of azoospermia, with particular emphasis on emerging regenerative and genetic therapeutic approaches.The reviewed highlights that non-obstructive azoospermia results from multifactorial disturbances involving hormonal imbalance, genetic defects, immune dysregulation, and disruption of the testicular microenvironment. The literature discussed in this review indicates that regenerative strategies such as platelet-rich plasma, stem cell-based approaches, and extracellular vesicles may contribute to testicular repair and support spermatogenic processes through modulation of cellular signaling and inflammatory pathways. In parallel, advances in genetic technologies, particularly CRISPR-based gene-editing tools, are presented as emerging strategies for targeting genes essential for spermatogenesis.Although clinical application remains early, these strategies show strong potential in reversing testicular damage. Continued research and clinical trials are essential to confirm safety, optimize protocols, and expand therapeutic use.

  • Open Access

    Safety and feasibility of intravenous fresh adipose-derived mesenchymal stem cells in secondary progressive multiple sclerosis: phase I/IIa clinical results

    by Fahimeh Lavi Arab, Forouzan Yousefi, Hojjat Naderi-Meshkin, Mahdi Mirahmadi, Fatemeh Faraji, Karim Nikkhah, Houshang Amiri, Marjan Erfani, Fatemeh Ayoobi, Nafiseh Sadat Tabasi, et al.

    Mesenchymal stem cells (MSCs) hold substantial promise in regenerative medicine owing to their immunomodulatory, neuroregenerative, and self-renewal proper


  • Open Access

    Effects of nanosilymarin and conditioned medium of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells co-cultured with HeLa cells

    by Nafiseh Daneshi, Mahmoud Mahmoudi, Seyed Abdolrahim Rezaee, Majid Khoshmirsafa, Niayesh Salar, Solmaz Kheradmand, Fahimeh Lavi Arab, Fatemeh Faraji

    Cervical cancer is the fourth most common malignancy in females worldwide. Silymarin, a flavonoid with established anti-inflammatory properties, shows prom

  • Open Access

    Hepatoprotective effects of extracted polysaccharide from brittle star ( Ophiocoma erinaceus ) against carbon tetrachloride-induced acute liver injury in rats

    by Mohammadreza Pourmohammad, Javad Baharara, Jina Khayatzadeh, Shima Afshari, Fahimeh Lavi Arab

    Background: The exploration of marine-derived natural products, particularly polysaccharides, has highlighted their significant hepatoprotective effects, showcasing their therapeutic potential in liver-related studies. This research concentrated on the extraction of total polysaccharides from the brittle star species Ophiocoma erinaceus (O. erinaceus). This study investigated the role of Persian Gulf brittle star polysaccharide (BSP) in immunotherapy and chemotherapy within a rat model of acute liver injury induced by carbon tetrachloride (CCl4). Methods: The dried brittle stars underwent mechanical grinding to facilitate the extraction of the polysaccharide. Subsequent to the CCl4 induction, the rats assigned to the BSP treatment group received intragastric administration of BSP at dosages of 12.5, 25, and 37.5 mg/kg body weight daily for seven days. We meticulously evaluated the levels of various biochemical markers. Moreover, Western blot analysis was conducted to ascertain the expression levels of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6, and adenosine A2A receptors. The rats were subjected to treatment with a 0.1% CCl4 solution (0.2 mL/10 g) mixed with soybean oil over the span of seven days. Results: The methodologies implemented for polysaccharide detection effectively isolated crude polysaccharides from the brittle star indigenous to the Persian Gulf. The treatment with BSP yielded a significant reduction in the expressions of IL-6 (5.75), TNF-α (2.115), and IL-1β (4.465) among rats subjected to CCl4 intoxication. Furthermore, the administration of BSP resulted in an upregulation of the adenosine A2A receptor (2.05) in these CCl4-intoxicated rats. Additionally, rats administered with BSP displayed notable enhancements in the activities of superoxide dismutase (SOD) (87.5%), catalase (CAT) (72.5%), glutathione peroxidase (GPx) (81.25%), and glutathione S-transferase (GST) (83.8%), accompanied by a significant decrease in reduced glutathione (GSH) levels (81.3%). Conclusion: The therapeutic efficacy of BSP is expected to extend to rats subjected to CCl4 intoxication. Recent investigations suggest that BSP may function as a therapeutic agent for these CCl4-intoxicated rats. Accordingly, these findings contribute novel insights into the hepatoprotective potential of BSP, establishing it as a promising candidate for hepatic treatment.

  • Open Access

    Nano-curcumin potentiates antitumor immunity in prostate cancer via co-culture with adipose-derived mesenchymal stem cells

    by Farid Zeynali, Melika Hadad Tehran, Fatemeh Faraji, Mahmoud Mahmoudi, Nafiseh Sadat Tabasi, Sevda Ghoreyshi, Fahimeh Lavi Arab

    Curcumin is a polyphenolic compound from Curcuma longa that exhibits immunoregulatory and anti-cancer properties. It is formulated as nano-curcumin. Mesenchymal stem cells (MSCs) also show anticancer effects and can potentially activate resting immune cells. This study investigates the combined effects of nano-curcumin and adipose-derived mesenchymal stem cells (ASCs) on peripheral blood mononuclear cells (PBMCs) isolated from prostate cancer (PCa) patients. ASCs were isolated and characterized. PBMCs were isolated from patients and co-cultured with and without ASCs in the presence of different concentrations of nano-curcumin to examine cell survival using the MTT assay. Based on the results of the MTT assay, selected concentrations of nano-curcumin were used to investigate apoptosis and cell subpopulations of PBMCs in co-culture with ASCs using apoptosis assay and flow cytometry. Nano-curcumin increased PBMC survival at concentrations of 3, 6, 12, 25, and 50 µM in co-culture with ASCs. In the absence of ASCs, a significant increase in PBMC survival was observed at concentrations of 6, 12, 25, 50, and100 µM. Concentrations of 6 and 12 µM caused a significant reduction in apoptosis. A concentration of 12 µM increased the number of CD3+CD4+ cells, and the number of CD3+CD8+ cells increased at concentrations of 6 and 25 µM. At a concentration of 25 µM, the number of CD45+CD19+ cells was significantly increased. Nano-curcumin in combination with ASCs has the potential to affect immune cells, indicating its potential as a complementary therapy for use in cancer. Further research is required to confirm these findings.


  • Open Access

    Ferroptosis induction by engineered liposomes for enhanced tumor therapy

    by Alireza Ghasempour, Mohammad Amin Tokallou, Mohammad Reza Naderi Allaf, Mohsen Moradi, Hamideh Dehghan, Mahsa Sedighi, Mohammad-Ali Shahbazi, Fahimeh Lavi Arab

    Ferroptosis has shown potential therapeutic effects in tumor therapy as an iron-dependent programmed cell death. The induction of ferroptosis is based on lipid peroxidation, the accumulation of iron and reactive oxygen species, and the depletion of glutathione. Nowadays, various nanoparticles are reported for ferroptosis-based therapy. Among them, engineered liposomes have received more attention due to their biocompatibility, low immunogenicity, and flexibility in chemical and structural modifications. The present review focuses on the mechanisms of ferroptosis and its induction by engineered liposomes to improve tumor therapy. It also highlights the fascinating outcome of liposome-mediated ferroptosis in overcoming the obstacles to cancer therapy, along with the limitations and possible future directions.


  • Effects of Probiotics on Liver Diseases: Current In Vitro and In Vivo Studies

    by Maryam Sadri, Zahra Shafaghat, Mona Roozbehani, Akram Hoseinzadeh, Fatemeh Mohammadi, Fahimeh Lavi Arab, Sara Minaeian, Soheil Rahmani Fard, Fatemeh Faraji

    Various types of liver or hepatic diseases cause the death of about 2 million people worldwide every year, of which 1 million die from the complications of cirrhosis and another million from hepatocellular carcinoma and viral hepatitis. Currently, the second most common solid organ transplant is the liver, and the current rate represents less than 10% of global transplant requests. Hence, finding new approaches to treat and prevent liver diseases is essential. In liver diseases, the interaction between the liver, gut, and immune system is crucial, and probiotics positively affect the human microbiota. Probiotics are a non-toxic and biosafe alternative to synthetic chemical compounds. Health promotion by lowering cholesterol levels, stimulating host immunity, the natural gut microbiota, and other functions are some of the activities of probiotics, and their metabolites, including bacteriocins, can exert antimicrobial effects against a broad range of pathogenic bacteria. The present review discusses the available data on the results of preclinical and clinical studies on the effects of probiotic administration on different types of liver diseases.